Abstract | OBJECTIVES/HYPOTHESIS: The inner ear rapidly mounts an immune response that can lead to cochlear degeneration and permanent hearing loss. Identification of proinflammatory cytokine expression during the initiation of the response should lead to rational therapeutic strategies that block the response, reducing damaging sequelae. STUDY DESIGN: A cochlear immune response to keyhole limpet hemocyanin (KLH) injected into the inner ear or subarachnoid space of sensitized animals was created. Etanercept was administered to a group of animals to blunt the immune response. METHODS: RESULTS: CONCLUSION:
|
Authors | Hitoshi Satoh, Gary S Firestein, Peter B Billings, Jeffrey P Harris, Elizabeth M Keithley |
Journal | The Laryngoscope
(Laryngoscope)
Vol. 112
Issue 9
Pg. 1627-34
(Sep 2002)
ISSN: 0023-852X [Print] United States |
PMID | 12352677
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Immunoglobulin G
- Immunosuppressive Agents
- Interleukin-1
- Interleukin-6
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha
- Hemocyanins
- Etanercept
|
Topics |
- Animals
- Cochlea
(immunology, metabolism)
- Etanercept
- Female
- Hemocyanins
(immunology)
- Immunoglobulin G
(pharmacology)
- Immunosuppressive Agents
(pharmacology)
- Interleukin-1
(metabolism)
- Interleukin-6
(metabolism)
- Mice
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha
(immunology)
|